Evidence map›Paper›PMID 39359530›Full record

ArticleJournal of ophthalmic & vision research

Evaluation of Foveal Vasculature by Optical Coherence Tomography Angiography after Pan-Retinal Photocoagulation versus Intravitreal Anti-VEGF Injections.

Hamid Riazi-Esfahani, Amin Ahmadi, Reza Sadeghi, Masoud Mirghorbani, Fariba Ghassemi, Mohammad Zarei, Hassan Khojasteh, Nikoo Bayan, Hooshang Faghihi, Elias Khalili Pour and 1 more

Abstract read
In one paragraph

Article in Journal of ophthalmic & vision research. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Hamid Riazi-EsfahaniRetina Service, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Amin AhmadiRetina Service, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Reza SadeghiRetina Service, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Masoud MirghorbaniRetina Service, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Fariba GhassemiRetina Service, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Mohammad ZareiRetina Service, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Hassan KhojastehRetina Service, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Nikoo BayanRetina Service, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Hooshang FaghihiRetina Service, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Elias Khalili PourRetina Service, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Ahmad MirshahiRetina Service, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: This study aimed to compare macular vascular changes one and three months after treatment with either panretinal photocoagulation (PRP) or intravitreal bevacizumab (IVB). Methods: A total of 62 eyes with very severe non-proliferative diabetic retinopathy or early proliferative diabetic retinopathy without center-involved diabetic macular edema, were included in this retrospective study. Thirty-nine eyes were allocated to the PRP group, while 23 eyes were treated with IVB. Optical coherence tomography angiography (OCTA) was performed to measure foveal avascular zone (FAZ) characteristics as well as the densities of superficial and deep capillary plexuses (SCP and DCP). Results: In the IVB group, the FAZ area and perimeter expanded at month one but returned to baseline level after three months. In the PRP group, however, the FAZ area and perimeter were rather steady. Changes in the FAZ area were significantly different between the treatment groups at month one ( Conclusion: Although bevacizumab and PRP have different short-term macular vascular responses, both therapies have the ability to normalize or stabilize vascular measures over time.

Indexed as

Anti-vascular Endothelial Growth FactorDiabetic RetinopathyFoveal Avascular ZoneOptical Coherence Tomography AngiographyPanretinal Photocoagulation

Identifiers

PMID39359530
PMCPMC11443997

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.